MBX-102/JNJ39659100, a Novel Non-TZD Selective Partial PPAR- Agonist Lowers Triglyceride Independently of PPAR- Activation

Use of Thiazolidinediones and Fracture Risk

(2008) Christian Meier et al.   ARCHIVES OF INTERNAL MEDICINE

Fibrate Therapy

(2008) Joshua Remick et al.   Cardiology in Review

Role of peroxisome-proliferator-activated receptor β/δ (PPARβ/δ) in gastrointestinal tract function and disease

(2008) Jeffrey M. Peters et al.   CLINICAL SCIENCE

Thematic Review Series: Skin Lipids.Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology

(2008) Matthias Schmuth et al.   JOURNAL OF LIPID RESEARCH

The PPAR trio: Regulators of myocardial energy metabolism in health and disease

(2008) Jose A. Madrazo et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies

(2008) Mark A. Deeg et al.   PPAR Research

TZDs and Bone: A Review of the Recent Clinical Evidence

(2008) Ann V. Schwartz   PPAR Research

Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention

(2008) Tianxin Yang et al.   PPAR Research

Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism

(2007) Sander Kersten   PPAR Research